Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Premacure AB
Headquarters:
Uppsala, Sweden
Website:
N/A
Year Founded:
2006
Status:
Acquired
BioCentury
|
Jul 11, 2016
Clinical News
Mecasermin rinfabate: Phase II data
Read More
BioCentury
|
Nov 18, 2013
Strategy
Shire goes vertical
Shire CEO amplifies on ViroPharma acquisition and rare disease strategy
Read More
BioCentury
|
May 20, 2013
Strategy
Let a thousand ideas bloom
How Shire is breaking the mold to fuel external discovery in rare diseases
Read More
BioCentury
|
May 3, 2013
Financial News
Shire reports 1Q13 earnings, unveils business changes
Read More
BioCentury
|
Apr 1, 2013
Company News
SARcode, Shire deal
Read More
BioCentury
|
Apr 1, 2013
Strategy
Shire sees opportunity
Incoming Shire CEO outlines ophthalmics strategy after SARcode, Premacure deals
Read More
BioCentury
|
Mar 26, 2013
Company News
Shire acquiring dry eye company SARcode
Read More
BioCentury
|
Mar 18, 2013
Company News
Premacure, Shire deal
Read More
BioCentury
|
Mar 13, 2013
Company News
Shire acquires rare eye disease company Premacure
Read More
BioCentury
|
Jun 29, 2009
Clinical News
iPlex mecasermin rinfabate: Phase II data
Read More
Items per page:
10
1 - 10 of 13